Clinical Trial Update: MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD [NA]

View source ↗

Summary

Clinical trial update on using MxA and CRP levels to guide antimicrobial therapy in acute exacerbations of COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Capital Medical University | Conditions: Acute Exacerbation Chronic Obstructive Pulmonary Disease | NA | Status: NOT_YET_RECRUITING